ImmunityBio, Inc.
IBRX · NASDAQ · USD
$9.91
+0.16 1.64%todayNot financial advice.
- Open
- 9.63
- Day range
- 9.43 - 10.05
- 52-week range
- 1.95 - 12.43
- Volume
- 10.49M
- Market cap
- 10.5B
- P/E ratio
- —
- EPS
- -0.97
- Dividend yield
- 0.00%
- Beta
- 1.25
Performance
W
+6.79%
1M
+23.88%
3M
+11.10%
6M
+34.83%
YTD
+390.59%
Y
+293.25%
5Y
+3.34%
All
−73.22%
In the news
Oct 8
ImmunityBio Executive Chairman Patrick Soon-Shiong to Present at Piper Sandler Virtual Oncology Symposium
ImmunityBio Founder Dr. Patrick Soon-Shiong will participate in a fireside chat on October 16 to discuss the company's immunotherapy pipeline.
Company news
Oct 8
ImmunityBio Shares Under Pressure Despite Founder Highlighting Cancer Care Initiative
Shares of ImmunityBio, Inc. (IBRX) fell 5% this week despite its founder highlighting a major cancer-care integration between sister firm NantIQ and Aetna.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-IBRX" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="ImmunityBio, Inc. (IBRX) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-IBRX">IBRX stock price</a> by FreeTheAI Stocks</p>